Health care company Baxter International, Inc. (BAX) reported Thursday a net loss attributable to shareholders for the first quarter of $15 million or $0.03 per share, compared to net income of $126 million or $0.25 per share in the prior-year quarter.
Excluding items, adjusted income from continuing operations for the quarter was $0.37 per share, compared to $0.62 per share last year.
Worldwide net sales for the quarter grew 3 percent to $2.70 billion from $2.63 billion in the same quarter last year. It declined 1 percent on an organic basis.
Continuing operations exclude Baxter's Kidney Care business, which was divested in January 2025, and is reported as discontinued operations.
Looking ahead to fiscal 2026, the company continues to project adjusted earnings from continuing operations in a range of $1.85 to $2.05 per share on sales growth from continuing operations of flat to 1 percent on a reported basis, with flat organic sales growth from continuing operations.
In Thursday's pre-market trading, BAX is trading on the NYSE at $17.66, up $0.75 or 4.47 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.